Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation: DESTINATION Study

NCT06615596 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

NCT NCT06615596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06615596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation: DESTINATION Study
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Phase 1
Overall status
Recruiting
Start date
August 5, 2025
Completion date
December 31, 2029
Enrollment
3,160 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af)